Iovance Biotherapeutics (IOVA) Invested Capital (2012)
Iovance Biotherapeutics (IOVA) posted quarterly Invested Capital of $250000.0 for Q4 2012, little changed quarter-over-quarter from $250000.0 in Q3 2012.
Iovance Biotherapeutics (IOVA) Invested Capital (2012) Analysis & Trends
Iovance Biotherapeutics (IOVA) has reported Invested Capital for 1 consecutive years, with $250000.0 the latest figure, recorded in Q4 2012.
- In Q4 2012, Invested Capital changed N/A year-over-year to $250000.0; the TTM figure through Mar 2015 stood at $250000.0 (changed N/A YoY), while the FY2012 annual figure was $250000.0, changed N/A from the prior year.
- Invested Capital was little changed at $250000.0 in Q4 2012 per IOVA's latest filing, from $250000.0 in the prior quarter.
- Across five years, Invested Capital topped out at $250000.0 in Q3 2012 and bottomed at $250000.0 in Q3 2012.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 190.90 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 2.57 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 380.00 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Iovance Biotherapeutics | 3.16 Bn | 2.86 Bn | 55.72 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2012 | 250,000.00 |
| Sep 30, 2012 | 250,000.00 |